FDA.reportPublic FDA data

Briviact 50 MG in 5 ML Injection

RxCUI
1739754
RxNorm name
Briviact 50 MG in 5 ML Injection
Display name
Briviact 50 MG in 5 ML Injection
Full name
Briviact 50 MG in 5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BriviactBRIVARACETAMUCB, Inc.3cf2f439-0e97-443e-8e33-25ecef616f6c2026-08-20Warnings, Adverse reactionsExact identifier
rxcui: 1739754

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3cf2f439-0e97-443e-8e33-25ecef616f6cBriviact 50 MG in 5 ML Injection [PSN] · 5 ML brivaracetam 10 MG/ML Injection [Briviact] [SBD] · 5 ML Briviact 10 MG/ML Injection [SY] · Briviact 50 MG per 5 ML Injection [SY]426These highlights do not include all the information needed to use BRIVIACT ® safely and effectively. See full prescribing information for BRIVIACT. BRIVIACT ® (brivaracetam) tablets, for oral use, CV BRIVIACT ® (brivaracetam) oral solution, CV BRIVIACT ® (brivaracetam) injection, for intravenous use, CV Initial U.S. Approval: 201620260513